Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ERC1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA554007
Description
Immunogen sequence: IIQPLLELDQ NRSKLKLYIG HLTTLCHDRD PLILRGLTPP ASYNLDDDQA AWENELQKMT RGQLQDELEK GERDNAELQE FANAILQQIA DHCPD Highest antigen sequence identity to the following orthologs: Mouse - 89%, Rat - 89%.
The protein encoded by this gene is a member of a family of RIM-binding proteins. RIMs are active zone proteins that regulate neurotransmitter release. This gene has been found fused to the receptor-type tyrosine kinase gene RET by gene rearrangement due to the translocation t(10;12)(q11;p13). Multiple transcript variants encoding different isoforms have been found for this gene.
Specifications
ERC1 | |
Polyclonal | |
Unconjugated | |
ERC1 | |
4930404L01Rik; 5033405M01Rik; 9630025C19Rik; B430107L16Rik; CAST; CAST2; CAZ-associated structural protein 2; Elks; ELKS/Rab6-interacting/CAST family member 1; ERC; ERC protein 1; Erc1; ERC-1; ERC1b; FLJ31750; KIAA1081; MGC12974; mKIAA1081; OTTHUMP00000160633; Rab6 interacting protein 2; RAB6-interacting protein 2; Rab6ip2; RAB6IP2A; RAB6IP2B; RIM-Binding Protein | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
111173, 23085, 266806 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q811U3, Q8IUD2, Q99MI1 | |
ERC1 | |
Recombinant protein corresponding to Human ERC1. Recombinant protein control fragment (Product #RP-92553). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction